Number of NAS approved by Health Canada 2011-2016
Number of new active substances (NASs) approved by Health Canada from 2011 to 2016*
This statistic depicts the number of new active substances (NASs) approved by Health Canada in Canada from 2011 to 2016. In 2011, 23 prescription pharmaceutical new active substances and three biologic new active substances were approved by Health Canada.
Number of new active substances (NASs) approved by Health Canada from 2011 to 2016*
Loading statistic...
| Prescription pharmaceutical | Biologic | |
|---|---|---|
| 2011 | 23 | 3 |
| 2012 | 21 | 2 |
| 2013 | 36 | 4 |
| 2014 | 22 | 3 |
| 2015 | 32 | 5 |
| 2016 | 27 | 11 |
Source
More information
Statistics on "Pharmaceutical trends in Europe"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Oncology or orphan drugs that were new active substances globally 2009-2017
- New active substances among brand drugs sales Canada 2017, by launch year
- Share of sales attributable to new active substances launched 2009-2016 by country
- New active substance approvals in OECD countries 2017, by country
- New NASs reviewed by medicine prices review board Canada 2011-2016 by improvement
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Number of medicines in development for heart disease and stroke by type 2018
- U.S. NDA/BLA filing approval for new drugs in select disease areas 2006-2015
- Probability of success for active substances to the market 2015
- U.S. pain medication clinical pipeline in 2017, by phase and indication
- Number of new pharmaceutical drug approvals in South Korea 2014 by therapeutic area
- Annual cost of MS drugs by select countries 2013-2014
- Annual cost of MS drugs in the United States from approval date to 2013
- NDA/BLA filing to FDA approval times for new drugs in select disease areas 2006-2015
- U.S. drug development Phase I to approval success rates 2006-2015 by disease area
- FDA approved orphan drugs 1983-2018, by approval sequence
- Total minority health funding by the National Institutes for Health 2013-2019
- Revenue since approval for select cancer drugs 2017
- Health care and medicine expense by insurance status in the U.S. 1987-2014
Statistics on "Pharmaceutical trends in Europe"
Related topics
About Statista
